Assignee
REDHILL BIOPHARMA LTD
IL·39 granted patents·8 pending applications·66 citations·filing 2012–2025
Top patents by PatentIndex Score
47 records- 0196US11052073B1Sphingosine kinase 2 inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Jul 6, 2021·6 cites·30 claims
- 0296US11045453B1Serine protease inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Jun 29, 2021·7 cites·30 claims
- 0394US11090325B2Compositions for treating ebola virus infectionREDHILL BIOPHARMA LTD·Filed 2020·Granted Aug 17, 2021·3 cites·22 claims
- 0494US10238606B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2017·Granted Mar 26, 2019·6 cites·6 claims
- 0593US11918560B2Serine protease inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Mar 5, 2024·2 cites·20 claims
- 0693US9603806B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2016·Granted Mar 28, 2017·5 cites·20 claims
- 0793US9498445B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2014·Granted Nov 22, 2016·7 cites·18 claims
- 0892US9844540B2Combination therapies for treating cancerREDHILL BIOPHARMA LTD·Filed 2016·Granted Dec 19, 2017·7 cites·17 claims
- 0990US11135172B2Rifabutin-based compositions and methods for treating Helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2019·Granted Oct 5, 2021·2 cites·13 claims
- 1088US12502381B2Serine protease inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2024·Granted Dec 23, 2025·0 cites·16 claims
- 1188US2024325313A1Pharmaceutical compositions for the treatment of helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2024·Application pending·0 cites
- 1287US12370206B2Therapy for inhibition of single-stranded RNA virus replicationREDHILL BIOPHARMA LTD·Filed 2023·Granted Jul 29, 2025·0 cites·13 claims
- 1387US9974800B2Therapy for inhibition of single-stranded RNA virus replicationREDHILL BIOPHARMA LTD·Filed 2015·Granted May 22, 2018·2 cites·8 claims
- 1486US10434114B2Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibioticsREDHILL BIOPHARMA LTD·Filed 2018·Granted Oct 8, 2019·2 cites·11 claims
- 1585US10543222B2Therapy for inhibition of single-stranded RNA virus replicationREDHILL BIOPHARMA LTD·Filed 2018·Granted Jan 28, 2020·3 cites·6 claims
- 1685US10493065B2Formulations and methods of manufacturing formulations for use in colonic evacuationREDHILL BIOPHARMA LTD·Filed 2018·Granted Dec 3, 2019·2 cites·20 claims
- 1785US2025325577A1Therapy for inhibition of single-stranded rna virus replicationREDHILL BIOPHARMA LTD·Filed 2025·Application pending·0 cites
- 1881US10765691B2Method for treating crohn's disease using triple antimicrobial all-in-one formulationREDHILL BIOPHARMA LTD·Filed 2019·Granted Sep 8, 2020·0 cites·3 claims
- 1980US11931463B2All-in-one fixed-dose combination for treating Helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Mar 19, 2024·0 cites·15 claims
- 2079US11364227B2Sphingosine kinase 2 inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Jun 21, 2022·0 cites·15 claims
- 2178US12551469B2Sphingosine kinase 2 inhibitor for treating coronavirus infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Feb 17, 2026·0 cites·15 claims
- 2278US11786541B2Inhibitor of sphingosine kinase 2 for treating EbolaREDHILL BIOPHARMA LTD·Filed 2021·Granted Oct 17, 2023·0 cites·20 claims
- 2377US10898439B2Methods for treating helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2019·Granted Jan 26, 2021·0 cites·20 claims
- 2476US10166219B2Formulations and methods of manufacturing formulations for use in colonic evacuationREDHILL BIOPHARMA LTD·Filed 2013·Granted Jan 1, 2019·3 cites·5 claims
- 2574US11090326B2Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimineREDHILL BIOPHARMA LTD·Filed 2020·Granted Aug 17, 2021·0 cites·16 claims
- 2674US10946000B2Method for treating cancer with combination therapyREDHILL BIOPHARMA LTD·Filed 2019·Granted Mar 16, 2021·0 cites·19 claims
- 2772US11633385B2Combination compositions for treatment of cancerREDHILL BIOPHARMA LTD·Filed 2021·Granted Apr 25, 2023·0 cites·19 claims
- 2872US11058671B2Formulations and methods of manufacturing formulations for use in colonic evacuationREDHILL BIOPHARMA LTD·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 2972US9901638B2Composition and method for treating an autoimmune diseaseREDHILL BIOPHARMA LTD·Filed 2012·Granted Feb 27, 2018·2 cites·11 claims
- 3070US10143702B2Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimineREDHILL BIOPHARMA LTD·Filed 2018·Granted Dec 4, 2018·0 cites·5 claims
- 3169US12115150B2Biomarkers of coronavirus pneumoniaREDHILL BIOPHARMA LTD·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 3268US12569475B2Method for eradicating helicobacter pylori infection in patients regardless of body mass indexREDHILL BIOPHARMA LTD·Filed 2023·Granted Mar 10, 2026·0 cites·19 claims
- 3368US11471448B2Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumoniaREDHILL BIOPHARMA LTD·Filed 2021·Granted Oct 18, 2022·0 cites·20 claims
- 3468US10105379B2Pharmaceutical compositions comprising three antibioticsREDHILL BIOPHARMA LTD·Filed 2017·Granted Oct 23, 2018·0 cites·6 claims
- 3568US2020330392A1Bimodal release ondansetron tablets and methods of treating nausea and vomitingREDHILL BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 3667US10463654B2Combination therapies for treating cancerREDHILL BIOPHARMA LTD·Filed 2017·Granted Nov 5, 2019·0 cites·12 claims
- 3765US10668050B2Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndromeREDHILL BIOPHARMA LTD·Filed 2017·Granted Jun 2, 2020·0 cites·5 claims
- 3863US2020253933A1Methods for treating diarrhea predominant irritable bowel syndromeREDHILL BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 3963US2016228464A1Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereofREDHILL BIOPHARMA LTD·Filed 2016·Application pending·0 cites
- 4062US9636305B2Antiemetic extended release solid dosage formsREDHILL BIOPHARMA LTD·Filed 2014·Granted May 2, 2017·0 cites·10 claims
- 4159US11590154B2Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infectionsREDHILL BIOPHARMA LTD·Filed 2021·Granted Feb 28, 2023·0 cites·20 claims
- 4257US2018028452A1Antiemetic extended release solid dosage formsREDHILL BIOPHARMA LTD·Filed 2017·Application pending·0 cites
- 4356US2017189340A1Antiemetic extended release solid dosage formsREDHILL BIOPHARMA LTD·Filed 2017·Application pending·0 cites
- 4453USD883801SBlister packageREDHILL BIOPHARMA LTD·Filed 2018·Granted May 12, 2020·7 cites·1 claims
- 4552US11878011B2Method for eradicating Helicobacter pylori infection in patients regardless of body mass indexREDHILL BIOPHARMA LTD·Filed 2020·Granted Jan 23, 2024·0 cites·16 claims
- 4648US9675588B2Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptomsREDHILL BIOPHARMA LTD·Filed 2015·Granted Jun 13, 2017·0 cites·16 claims
- 4742US2019022088A1Use of wx-uk1 and its prodrug, wx-671, for the treatment of non-cancerous medical conditionsREDHILL BIOPHARMA LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REDHILL BIOPHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →